This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Detroit, Mich., Feb. 17, 1904.
To the Editor:
—We have read the editorial, "The Cost of Production of Diphtheria Antitoxin," on page 471 of The Journal, February 13. It is an interesting article—interesting for what it states, and especially interesting for what it omits to state regarding this responsible, difficult and expensive work. Will you permit us to point out a few of the conspicuous omissions? For example:Your editorial omits to state what is incontestably true— that the private producers of antitoxin are subject to federal license and to rigid federal supervision, from which the Massachusetts State Board of Health is exempt, since it does not engage in interstate traffic. The representative of the U. S. Public Health and Marine-Hospital Service goes into the biologic laboratories and stables of every private producer in this country and dictates what his equipment shall be. And if the commands of that representative—for
The Cost of Production of Diphtheria Antitoxin. JAMA. 1904;XLII(9):602–603. doi:https://doi.org/10.1001/jama.1904.02490540034012
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: